Company / Working Capital
aTYR PHARMA INC Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$65.1M
FY2025
5-year range
$65.1M / $107.6M
FY2021-FY2025
Trend
-2.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from $19M in FY2019 to $108M in FY2021.
Based on SEC 10-K filings.
$65M in FY2025 with a 5-year CAGR of +17.0%.
Declined from $87M to $65M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, working capital decreased 2.8% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $65.1M | -2.8% |
| FY2024 | $67.0M | -22.6% |
| FY2023 | $86.6M | +29.2% |
| FY2022 | $67.0M | -37.7% |
| FY2021 | $107.6M | +262.5% |
| FY2020 | $29.7M | +56.1% |
| FY2019 | $19.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026